NCT00020969 - Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes | Biotech Hunter

Timeline

Start Date

March 31, 2001

Primary Completion Date

January 31, 2005

Study Completion Date

January 31, 2005

Conditions

LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms

Interventions

DRUG

arsenic trioxide

Trial Locations (8)

Georgia Cancer Specialists - Northside Office, Atlanta

Lynn Regional Cancer Center West, Boca Raton

Corpus Christi Cancer Center, Corpus Christi

Arizona Cancer Center at University of Arizona Health Sciences Center, Tucson

Green Cancer Center at Scripps Clinic, La Jolla

USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

St. Joseph Hospital Regional Cancer Center - Orange, Orange